Eli Lilly and Company (ETR:LLY)
662.90
-1.00 (-0.15%)
Jul 7, 2025, 11:39 AM CET
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $12.73B USD in the quarter ending March 31, 2025, with 45.17% growth. This brings the company's revenue in the last twelve months to $49.00B, up 36.38% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$49.00B
Revenue Growth
+36.38%
P/S Ratio
13.14
Revenue / Employee
$1.04M
Employees
47,000
Market Cap
595.85B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
Eli Lilly and Company News
- 3 days ago - Lilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns. - Barrons
- 3 days ago - Tech stocks soar: Semiconductors and software lead market gains - Forexlive
- 4 days ago - Top 50 High-Quality Dividend Stocks For July 2025 - Seeking Alpha
- 5 days ago - This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk - The Motley Fool
- 5 days ago - Top 15 High-Growth Dividend Stocks For July 2025 - Seeking Alpha
- 5 days ago - Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report - Benzinga
- 5 days ago - Major insurance changes are coming to GLP-1 drugs for weight loss. Heres how that could affect patients - Yahoo
- 6 days ago - Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment? - Investor's Business Daily